USANA HEALTH SCIENCES INC 8-K

What Happened
USANA Health Sciences, Inc. filed a Form 8‑K on January 12, 2026 to furnish a press release announcing preliminary net sales for the fiscal year ended January 3, 2026 and initial net sales guidance for the fiscal year ending January 2, 2027. The press release is attached to the 8‑K as Exhibit 99.1.

Key Details

• Filing date: January 12, 2026.
• Announced items: preliminary net sales for fiscal year ended January 3, 2026 and initial net sales guidance for fiscal year ending January 2, 2027.
• Exhibit: Press release furnished as Exhibit 99.1 to the Form 8‑K (figures/details are in the attached release).
• Disclosure note: Information is furnished (not “filed”) and the company states it is not intended to constitute a Regulation FD filing or be incorporated by reference into other filings. The Form 8‑K is signed by CFO G. Douglas Hekking.

Why It Matters
USANA’s preliminary net sales and initial guidance are the company’s latest revenue signals and can influence investor expectations, analyst revenue forecasts, and near‑term stock performance. Because the 8‑K furnishes — rather than files — the press release, investors should review Exhibit 99.1 for the specific sales figures and watch for subsequent formal filings (quarterly/annual reports) for audited results and further financial detail.